Summary Viralytics Ltd (Viralytics), formerly Psiron Limited is a biotechnology company that develops oncology products. The company develops and markets oncolytic immunotherapies for the treatment of different types of cancers. It offers cavataktm, a proprietary formulation for the common cold Coxsackievirus Type A21 (CVA21), is being evaluated in phase 1 and 2 clinical trials. Viralytics’ cavataktm is an oncolytic common cold virus that has demonstrated anti-tumor activity, by following a process called lysis. The company’s products are evaluated both as an intratumoural and intravenous agent in melanoma, prostate, lung and bladder cancers. It conducts research and development through medical research institutes and research facilities in Newcastle, Australia. Viralytics is headquartered in Sydney, New South Wales, Australia. Viralytics Ltd (VLA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.... Research Beam Model: Research Beam Product ID: 2114448 250 USD New
Viralytics Ltd (VLA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Viralytics Ltd (VLA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Healthcare
  • Published On : September   2017
  • Pages : 38
  • Publisher : GlobalData
 
 
 
Summary

Viralytics Ltd (Viralytics), formerly Psiron Limited is a biotechnology company that develops oncology products. The company develops and markets oncolytic immunotherapies for the treatment of different types of cancers. It offers cavataktm, a proprietary formulation for the common cold Coxsackievirus Type A21 (CVA21), is being evaluated in phase 1 and 2 clinical trials. Viralytics’ cavataktm is an oncolytic common cold virus that has demonstrated anti-tumor activity, by following a process called lysis. The company’s products are evaluated both as an intratumoural and intravenous agent in melanoma, prostate, lung and bladder cancers. It conducts research and development through medical research institutes and research facilities in Newcastle, Australia. Viralytics is headquartered in Sydney, New South Wales, Australia.

Viralytics Ltd (VLA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Viralytics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Viralytics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Viralytics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Viralytics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Viralytics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Viralytics Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Viralytics Enters into Agreement with Merck 10
Viralytics Enters into Partnership with University of Surrey 11
Equity Offering 12
Viralytics Raises USD3 Million in Share Purchase Plan 12
Viralytics Raises USD20.8 Million in Private Placement of Shares 14
Viralytics Completes Second Tranche Of Private Placement Of Shares For US$20.2Million 16
Viralytics Completes Rights Offering Of Shares For US$3.6 Million 18
Viralytics Ltd - Key Competitors 19
Viralytics Ltd - Key Employees 20
Viralytics Ltd - Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
Aug 18, 2017: Viralytics Annual Report and Full Year Financial Results 22
Product News 24
11/22/2016: Viralytics Announces Formation of Clinical Advisory Board 24
03/15/2016: Positive CAVATAK Clinical Data Presented at 2016 European Association of Urology Congress 25
Clinical Trials 26
Apr 05, 2017: Viralytics moves into the Expansion Phase and Reports on Progress in the CAVATAK and KEYTRUDA Combination KEYNOTE-200 clinical trial at AACR Conference 26
Apr 05, 2017: Viralytics' CAVATAK in Combination with YERVOY Provides Promising Results in Advanced Melanoma from the Phase 1b MITCI clinical study 27
Mar 02, 2017: Viralytics to Present New CAVATAK Clinical Data at American Association for Cancer Research Annual Meeting 2017 29
Oct 04, 2016: Viralytics Presents CAVATAK Trial Results at Oncolytic Virus Therapeutics Conference 31
Jun 06, 2016: Updated clinical trial data on CAVATAK tumour targeting and immune-activation presented at the American Society Clinical Oncology Annual Meeting 33
Apr 19, 2016: Positive Clinical Data from CAVATAK and YERVOY Combination presented at the 2016 AACR Annual Meeting 35
Apr 18, 2016: Further Promising CAVATAK Trial Data to be presented at Association for Cancer Research Annual Meeting 36
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Viralytics Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Viralytics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Viralytics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Viralytics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Viralytics Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Viralytics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Viralytics Enters into Agreement with Merck 10
Viralytics Enters into Partnership with University of Surrey 11
Viralytics Raises USD3 Million in Share Purchase Plan 12
Viralytics Raises USD20.8 Million in Private Placement of Shares 14
Viralytics Completes Second Tranche Of Private Placement Of Shares For US$20.2Million 16
Viralytics Completes Rights Offering Of Shares For US$3.6 Million 18
Viralytics Ltd, Key Competitors 19
Viralytics Ltd, Key Employees 20
Viralytics Ltd, Other Locations 21
List of Figures
Viralytics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Viralytics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Viralytics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Viralytics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Viralytics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Viralytics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Viralytics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Viralytics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter